Global Clinical Risk Grouping Solutions Market to Reach $2.3 Billion by 2030
The global market for Clinical Risk Grouping Solutions estimated at US$918.5 Million in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Dashboard Analytics segment is estimated at 13.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $237.1 Million, While China is Forecast to Grow at 18% CAGR
The Clinical Risk Grouping Solutions market in the U.S. is estimated at US$237.1 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$565.8 Million by the year 2030 trailing a CAGR of 18% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.3% and 11.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$364.2 Million by the year 2030.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook